Tranexamic Acid Does Not Up Functional Outcome After Major Trauma
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, June 15, 2023 -- For adults with major trauma at risk for trauma-induced coagulopathy, tranexamic acid administered before hospital admission is not associated with improvement in favorable functional outcome at six months, according to a study published online June 14 in the New England Journal of Medicine to coincide with the annual Critical Care Reviews Meeting, held from June 14 to 16 in Belfast, Ireland.
Russell L. Gruen, M.B., B.S., Ph.D., from the Australian National University in Canberra, and colleagues randomly assigned adults with major trauma who were at risk for trauma-induced coagulopathy to receive tranexamic acid administered before hospital admission and after arrival at the hospital or matched placebo (661 and 646 patients, respectively).
The researchers found that survival with a favorable functional outcome at six months occurred in 53.7 and 53.5 percent of patients in the tranexamic acid and placebo groups, respectively (risk ratio, 1.00; 95 percent confidence interval, 0.90 to 1.12; P = 0.95). At 28 days after injury, 17.3 and 21.8 percent of patients in the tranexamic acid and placebo groups, respectively, had died (risk ratio, 0.79; 95 percent confidence interval, 0.63 to 0.99), and by six months, 19.0 and 22.9 percent had died (risk ratio, 0.83; 95 percent confidence interval, 0.67 to 1.03). There was no meaningful difference observed between the groups in the number of serious adverse events, including vascular occlusive events.
"The results appear to confirm the early survival benefit of tranexamic acid, but no benefit with respect to a favorable functional outcome at six months," write the authors of an accompanying editorial.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Disparities in Direct Oral Anticoagulant Initiation Have Declined in Recent Years
FRIDAY, May 10, 2024 -- Historical disparities in initiation of direct oral anticoagulants (DOACs) for atrial fibrillation have lessened for Black and Hispanic patients, according...
Earlier Receipt of Whole Blood Transfusion Improves Survival
WEDNESDAY, Feb. 7, 2024 -- For patients presenting with severe hemorrhage, receipt of whole blood (WB) transfusion earlier within the first 24 hours of emergency department...
Little Change Seen in Rates of ED Discharge After Acute Pulmonary Embolism
MONDAY, Jan. 29, 2024 -- For patients with acute pulmonary embolism (PE), the rates of discharge from the emergency department were stable between 2012 and 2020, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.